Keyphrases
Glioblastoma Immunotherapy
100%
Stem Cell Carrier
100%
Neural Stem Cells
100%
Glioblastoma
100%
T Cells
66%
Glioma Cells
50%
Bispecific
33%
Tumor Cells
33%
Off-target Effects
16%
Tumor Cell Interaction
16%
ScFv Antibody
16%
Single-chain Antibody
16%
Neoplastic Cells
16%
Renal Clearance
16%
Clinical Model
16%
Antibody Expression
16%
Antibody-mediated
16%
Antibody Secretion
16%
Efficient Delivery
16%
Retargeting
16%
Continuous Infusion
16%
Hybridoma Cell Line
16%
Systemic Delivery
16%
Intranasal Delivery
16%
Mesenchymal Subtype
16%
Therapeutic Approaches
16%
Gene Signature
16%
Cell Surface Receptor
16%
Brain Cells
16%
Clinical Application
16%
Patient Outcomes
16%
Tumor Antigen
16%
Cancer Therapy
16%
Brain Cancer Cells
16%
Cell-to-cell
16%
Adenovirus
16%
Tumor Site
16%
Antitumor Immune Response
16%
Highly Aggressive
16%
Therapeutic Effect
16%
Antitumor Efficacy
16%
Genetic Modification
16%
Brain Cancer
16%
Treatment Toxicity
16%
Short Half-life
16%
Monoclonal Antibody
16%
Delivery Strategy
16%
Local Delivery
16%
Therapeutic Payload
16%
Patient-derived Xenograft
16%
Success Strategies
16%
Glioblastoma Cells
16%
Therapeutic Potential
16%
Tumor
16%
Local Immune Response
16%
Immune-competent
16%
High Affinity
16%
Chimeric Antigen Receptor T Cells (CAR-T)
16%
Cell Tumor
16%
Normal Brain
16%
Patient Prognosis
16%
Specific Targeting
16%
Medicine and Dentistry
Glioblastoma
100%
Neural Stem Cell
100%
Immunotherapy
100%
Tumor Cell
50%
Neoplasm
50%
T Cell
50%
Glioma Cell
37%
Single Chain Fragment Variable Antibody
25%
Immune Response
25%
Cell Interaction
12%
Xenograft
12%
Cell Surface Receptor
12%
Chimeric Antigen Receptor T-Cell
12%
In Vitro
12%
Continuous Infusion
12%
Adenoviridae
12%
Renal Clearance
12%
Therapy Effect
12%
Brain Cell
12%
Secretion (Process)
12%
Tumor Antigen
12%
Hybridoma Cell Line
12%
Cancer Therapy
12%
Gene Expression Profiling
12%
Brain Cancer in Adults
12%
Monoclonal Antibody
12%
Immunity
12%
Intracranial Tumor
12%
Immunology and Microbiology
Neural Stem Cell
100%
Immunotherapy
100%
Tumor Cell
66%
T Cell
66%
Immunology
66%
Glioma Cell
50%
Single-Chain Variable Fragment
33%
Immune Response
33%
Xenograft
16%
Monoclonal Antibody
16%
Renal Clearance
16%
DNA Modification
16%
Hybridoma Cell Line
16%
Secretion (Process)
16%
Cell Surface
16%
Brain Cell
16%
Cell Interaction
16%
Chimeric Antigen Receptor T-Cell
16%
Adenoviridae
16%
Tumor Antigen
16%
Gene Expression Assay
16%
Immunity
16%